CompletedNCT00538122
24-hour heart-rhythm monitoring while taking thioridazine
About this title
Read the official source — NCT00538122Observational studyAges 18–65United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- NashvilleSee all locations and recruitment
Study information
Study start dateJuly 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 12
- Sponsor
- Vanderbilt University
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00538122
- Official title
Show the full official title
Evaluating the Risks of Arrhythmia and Sudden Death Associated With Antipsychotic Drugs by Assessing the T Wave Abnormalities in the Holter Electrocardiogram
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Nashville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Vanderbilt University, a university.
Who was this study for?
Listed age limits: 18 years to 65 years.
